Yufang Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yufang Lv has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Aruo Nan
School of Public Health, Guangxi Medical University, Nanning 530021, China; Guangxi Key Laboratory of Environment and Health Research, Guangxi Medical University, Nanning 530021, China
24 shared publications - Bingqian Guo
Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, P.R. China
24 shared publications - Cheng Su
Department of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
24 shared publications - Deyun Liu
Department of Pediatrics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
24 shared publications - Haibiao Yan
Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P.R. China
24 shared publications - Haotian Xu
Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi, P.R. China
24 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
SP6 scaffolds DNA-PKcs and recruits PP2A to license DNA damage repair in human multipotent trophoblasts
- 17 November 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessSP6 scaffolds DNA-PKcs and recruits PP2A to license DNA damage repair in human multipotent trophoblasts
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S19 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
QPCR results of the expression of 4 deferent lncRNA in cytoplasm and nucleus. Three PCR by-wells were prepared for each sample.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S19 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
QPCR results of the expression of 4 deferent lncRNA in cytoplasm and nucleus. Three PCR by-wells were prepared for each sample.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S20 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
QPCR results after ASO (5717 and 5608) treatment of 2 lncRNAs in caki-2 and 786-O cell lines.Three or six PCR by-wells were prepared for each sample. NC, negative control.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S20 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
QPCR results after ASO (5717 and 5608) treatment of 2 lncRNAs in caki-2 and 786-O cell lines.Three or six PCR by-wells were prepared for each sample. NC, negative control.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S8 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
SNV was detected by whole-exome sequencing of 19 ccRCC samples.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
SNV was detected by whole-exome sequencing of 19 ccRCC samples.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S9 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
INDEL was detected by whole-exome sequencing of 19 ccRCC samples.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
INDEL was detected by whole-exome sequencing of 19 ccRCC samples.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
Clear cell renal cell carcinoma (ccRCC) frequently features a high level of tumor heterogeneity. Elucidating the chromatin landscape of ccRCC at the single-cell level could provide a deeper understanding of the functional states and regulatory dynamics underlying the disease. Here, we performed single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) on 19 ccRCC samples, and whole-exome sequencing was used to understand the heterogeneity between individuals. Single-cell transcriptome and chromatin accessibility maps of ccRCC were constructed to reveal the regulatory characteristics of different tumor cell subtypes in ccRCC. Two long noncoding RNAs (RP11-661C8.2 and CTB-164N12.1) were identified that promoted the invasion and migration of ccRCC, which was validated with in vitro experiments. Taken together, this study comprehensively characterized the gene expression and DNA regulation landscape of ccRCC, which could provide new insights into the biology and treatment of ccRCC.Significance:A comprehensive analysis of gene expression and DNA regulation in ccRCC using scATAC-seq and scRNA-seq reveals the DNA regulatory programs of ccRCC at the single-cell level.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
Clear cell renal cell carcinoma (ccRCC) frequently features a high level of tumor heterogeneity. Elucidating the chromatin landscape of ccRCC at the single-cell level could provide a deeper understanding of the functional states and regulatory dynamics underlying the disease. Here, we performed single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) on 19 ccRCC samples, and whole-exome sequencing was used to understand the heterogeneity between individuals. Single-cell transcriptome and chromatin accessibility maps of ccRCC were constructed to reveal the regulatory characteristics of different tumor cell subtypes in ccRCC. Two long noncoding RNAs (RP11-661C8.2 and CTB-164N12.1) were identified that promoted the invasion and migration of ccRCC, which was validated with in vitro experiments. Taken together, this study comprehensively characterized the gene expression and DNA regulation landscape of ccRCC, which could provide new insights into the biology and treatment of ccRCC.Significance:A comprehensive analysis of gene expression and DNA regulation in ccRCC using scATAC-seq and scRNA-seq reveals the DNA regulatory programs of ccRCC at the single-cell level.